Literature DB >> 10688830

A monoclonal antibody specific to the granulocyte-derived elastase-fragment D species of human fibrinogen and fibrin: its application to the measurement of granulocyte-derived elastase digests in plasma.

I Kohno1, K Inuzuka, Y Itoh, K Nakahara, Y Eguchi, T Sugo, G Soe, Y Sakata, H Murayama, M Matsuda.   

Abstract

When granulocytes are stimulated under certain clinical conditions, elastase is released therefrom and digests fibrin(ogen) independently of the plasmin system, which may also be mobilized simultaneously. Thus, discrimination of these 2 systems becomes urgent for the diagnosis and treatment of the underlying diseases. Using as immunogen a 97-kd granulocyte-elastase digest of human fibrinogen, we raised an antibody IF-123 that specifically recognizes elastase digests of human fibrin(ogen). The 97-kd elastase fragment resembles plasmic fragment D(1), and the epitope of this antibody is located on the Aalpha (196-204) residue segment. This segment appears to be masked in fibrin(ogen) but exposed when the Aalpha Leu 204-Ile 205 peptide bond is cleaved by elastase. Cathepsin G concomitantly released from granulocytes failed to expose the epitope. By an enzyme immunoassay using IF-123 as the capture antibody, the elastase digests of fibrin(ogen) can be measured in plasma samples without interference by abundantly coexisting fibrinogen. Indeed, we found that the elastase digests were mostly elevated in patients with inflammation or malignant tumors, but remained in a normal range in patients with a benign gastrointestinal tract disease such as duodenal ulcer and polyps in the gallbladder or the colon. Like the plasmic D-dimer, the elastase digests predominantly consisted of the DD/E complex and DD/E-containing high-molecular weight derivatives apparently corresponding to the phase-3 plasmic digests of cross-linked fibrin. (Blood. 2000;95:1721-1728)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688830

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury.

Authors:  Junichi Hirahashi; Keiichi Hishikawa; Shinya Kaname; Naotake Tsuboi; Yunmei Wang; Daniel I Simon; George Stavrakis; Tatsuo Shimosawa; Ling Xiao; Yutaka Nagahama; Kazuo Suzuki; Toshiro Fujita; Tanya N Mayadas
Journal:  Circulation       Date:  2009-09-14       Impact factor: 29.690

2.  Clinical significance of plasma D-dimer and von Willebrand factor levels in patients with ulcer colitis.

Authors:  Gang Xu; Ke-Li Tian; Guo-Ping Liu; Xue-Jun Zhong; Shao-Ling Tang; Yan-Ping Sun
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

3.  Molecular pathogenesis of plasminogen Hakodate: the second Japanese family case of severe type I plasminogen deficiency manifested late-onset multi-organic chronic pseudomembranous mucositis.

Authors:  Tsukasa Osaki; Masayoshi Souri; Young-Seok Song; Naohiro Izumi; Ruby Law; Akitada Ichinose
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

4.  Contribution of neutrophil elastase to the lysis of obliterative thrombi in the context of their platelet and fibrin content.

Authors:  Gyöngyi Rábai; Nóra Szilágyi; Péter Sótonyi; Ilona Kovalszky; László Szabó; Raymund Machovich; Krasimir Kolev
Journal:  Thromb Res       Date:  2010-08       Impact factor: 3.944

Review 5.  Recent advances in disseminated intravascular coagulation: endothelial cells and fibrinolysis in sepsis-induced DIC.

Authors:  Seiji Madoiwa
Journal:  J Intensive Care       Date:  2015-02-19

Review 6.  Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis.

Authors:  Hidesaku Asakura; Hoyu Takahashi; Toshimasa Uchiyama; Yutaka Eguchi; Kohji Okamoto; Kazuo Kawasugi; Seiji Madoiwa; Hideo Wada
Journal:  Thromb J       Date:  2016-09-28

7.  Plasma levels of leucocyte elastase-generated cross linked fibrin degradation products (E-XDP) are elevated in chronic venous disease.

Authors:  Helen Sinabulya; Angela Silveira; Lena Blomgren; Joy Roy
Journal:  PLoS One       Date:  2021-12-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.